Aller au contenu principal
Profil bibliographique

Samia Cheriet

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées
181Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsGenetic Neurodegenerative DiseasesIntracerebral and Subarachnoid Hemorrhage Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Estimating the prevalence of amyloid positivity among older adults without dementia in the general population

Lisa Le Scouarnec, Vincent Bouteloup, Timothy Daly, Vincent Planche et autres

Abnormal brain accumulation of amyloid-β peptides, represents one of the earliest biological indicators of Alzheimer’s disease (AD) risk. Estimation on amyloid positivity (A + ) prevalence among older adults without dementia are needed to assess the epidemiological impact of AD diagnosis solely …

fr (code pays fourni par la source)

0 citations npj Dementia
Accès ouvert 2026 article OpenAlex

Methodological approaches to account for assay changes in longitudinal biomarker analysis: insights from Alzheimer’s blood biomarkers in the MEMENTO cohort

Vincent Bouteloup, Cécile Proust-Lima, Isabelle Pellegrin, Andréa Boizard-Moracchini et autres

BACKGROUND: Longitudinal studies allow the modelling of disease progression through repeated measurement of health outcomes, such as biomarkers. Changes in measurement tools over time, due to logistical or financial constraints, may challenge the statistical modeling of outcome trajectories. This study aims to …

fr (code pays fourni par la source)

0 citations Alzheimer s Research & Therapy
Accès ouvert 2025 article OpenAlex

Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab

Kirsten I. Taylor, Florian Lipsmeier, Marzia A. Scelsi, Ekaterina Volkova-Volkmar et autres

Digital health technology (DHT) tools for Parkinson's disease (PD) e.g., smartphones and wearables were used for remote and frequent measurement of motor signs in the phase 2 PASADENA study of the anti-alpha-synuclein monoclonal antibody prasinezumab. 316 early-stage PD participants were randomized to …

ch, gb, fr, us, ca, de, es, at (code pays fourni par la source)

14 citations npj Digital Medicine
Accès ouvert 2025 article OpenAlex

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

Vincent Bouteloup, Nicolas Villain, Jean‐Sébastien Vidal, Fernando González‐Ortiz et autres

Importance: Blood phosphorylated tau 217 (p-tau217) showed good performance in predicting brain amyloidosis. However, the importance of detailed cognitive phenotyping in patients without dementia when interpreting p-tau217 results remains unclear. Objective: To assess whether accuracy, negative predictive value (NPV), and positive predictive …

fr, se (code pays fourni par la source)

32 citations JAMA Neurology
Accès ouvert 2021 article OpenAlex

Diabetes Mellitus and Cognition

Éric Frison, Cécile Proust‐Lima, Jean‐François Mangin, Marie‐Odile Habert et autres

ObjectiveTo assess the role of biomarkers of Alzheimer disease (AD), neurodegeneration, and small vessel disease (SVD) as mediators in the association between diabetes mellitus and cognition. MethodsThe study sample was derived from MEMENTO, a cohort of French adults recruited in memory clinics …

fr, us, ca (code pays fourni par la source)

43 citations Neurology
Accès ouvert 2018 article OpenAlex

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

Paul McNulty, Richard Pilcher, Renata Necuiniate, Alis Hughes et autres

BACKGROUND: People with Huntington's disease (HD) have been observed to have lower rates of cancers. OBJECTIVE: To investigate the relationship between age of onset of HD, CAG repeat length, and cancer diagnosis. METHODS: Data were obtained from the European Huntington's disease network …

gb, at, de, fr, be, cz, dk, ax, se, fi (code pays fourni par la source)

37 citations Journal of Huntington s Disease
2016 article OpenAlex

Clinical manifestations of intermediate allele carriers in Huntington disease

Esther Cubo, María A. Ramos-Arroyo, Saül Martínez‐Horta, Asunción Martínez-Descalls et autres

OBJECTIVE: There is controversy about the clinical consequences of intermediate alleles (IAs) in Huntington disease (HD). The main objective of this study was to establish the clinical manifestations of IA carriers for a prospective, international, European HD registry. METHODS: We assessed a …

es (code pays fourni par la source)

55 citations Neurology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.